Avastin challenges Lucentis dominance in wet AMD

Avastin challenges Lucentis dominance in wet AMD

Posted on 26th April 2012

The leading wet AMD treatment used in the NHS, Lucentis, is under pressure from a cheaper version called Avastin.

Both compounds are from the family of AntiVEGF drugs (anti-vascular endothelial growth factor). In wet AMD, the degeneration causes the retina to make tiny new blood vessels in response to damage. These blood vessels are very fragile and break and bleed into the retina causing scarring and eventually vision loss.

AntiVEGF drugs stop and even shrink the growth of these new blood vessels preventing the damaging bleeding. Until now Lucentis has been the only approved drug for use in the eye and costs over £700 per injection (used in multiples of 3 injections normally). Avastin is in the same family of drugs and currently used to treat heart conditions. Costing only £60 per injection, many specialists in other countries have been using it ‘off label’ in the eye to great effect.

Avastin is now being used to treat 50% of AMD cases in the US and there is increasing pressure on the NHS to approve the use of this drug enabling far more access to the sight saving treatment.

At Cameron Optometry, we’re experts in all forms of macular disease and have the latest OCT technology which is used by specialists to diagnose and monitor the effects of treatment on wet AMD. If you are concerned or have a family history of the condition, come and see us for some expert advice.


Related Posts

First optometrist in Scotland to offer new Myopia Management contact lenses

29th March 2017

We were amongst a select group of eye care professionals across Europe who were invited to be the first to work with the new CooperVision MiSight® 1 day contact lens for Myopia Management. This is th...

Read more

Welcome to our head of retail, Gillian Sibeth

20th March 2017

We are delighted to welcome Gillian Sibeth as our head of retail at Cameron Optometry. She graduated in 1995 with the Fellowship Diploma of the Association of British Dispensing Opticians and has work...

Read more

How to ensure glaucoma is detected early

15th March 2017

This week is World Glaucoma Week which has prompted us to encourage people to ensure they have regular checks. The earlier signs are spotted, the earlier it can be managed and treated. Our optometrist...

Read more

Cameron Optometry shortlisted for Independent Practice of the Year Award

20th February 2017

We are delighted to announce that we have been shortlisted for UK Independent Practice of the Year at the Optician Awards 2017. The judges have debated, scrutinised and voted on every entry and we ...

Read more